recommendations for management of the trastuzumab (herceptin) among iranian breast cancer patients, a policy brief
نویسندگان
چکیده
introduction: allocation of the new (expensive) drugs for difficult refractory diseases and financial protection of the patients is an important challenge in the national health systems worldwide especially in developing countries.â trastuzumab (herceptin) as one of the effective but expensive drugs, put major financial burden for the iranian patients and government. so the ministry of health and medical education (mohme), decided to implement a national program for appropriate management of breast cancer and regulation of trastuzumab in i.r of iran (npmbct). in this policy brief we evaluated this issue and provided necessary recommendations. method: we designed a conceptual model consisting of the goals, main and supporting processes for management of trastuzumab in the national program. five macro-processes selected as the main concerns. then an expert panel including different scientific disciplines discussed the different aspects of the issue and provided the necessary recommendations. we determined the link between the suggested recommendations and the objectives of the program. results: based on the five selected main processes, the experts provided 10 recommendations including: 1) balance in the resource allocation, 2) appropriate modeling for the subsides allocation, 3) avoiding “poor subsidize the rich†phenomenon, 4) development and updating the clinical guidelines, 5) cost-effectiveness analysis on accepted guideline, 6) quality improvement of diagnostic tests, 7) standardization of the laboratory kits, 8) brand management and lowering the drug cost, 9) improving the patient registry system by ict infra-structure, 10) development of expert systems to empower the diagnostic laboratories. conclusion: given these recommendations, the npmbct program will be a successful model for the appropriate management of the expensive drugs and treatment of breast cancer in i.r. of iran and other developing countries.
منابع مشابه
Trastuzumab (herceptin) for early-stage breast cancer.
Breast cancer patients who have HER2 gene amplification and, consequently, protein overexpression, generally show an aggressive course with short disease-free and overall survivals. Trastuzumab, a humanized monoclonal antibody against the extracellular domain of HER2 protein, has been shown to benefit patients who have HER2-positive metastatic breast cancer, and recently, the results of five ad...
متن کاملThe Study of DNA Methyltransferase-3B Promoter Variant Genotype among Iranian Sporadic Breast Cancer Patients
Background: DNA methyltransferase-3B (DNMT3B) is an important enzyme responsible for maintaining the DNA methylation pattern in eukaryotic cells. In this study we have investigated the correlation between the 46359C→T polymorphism in the DNMT3B gene and the risk of breast cancer incidence among sporadic breast cancer patients in Fars Province, Southern Iran.Methods: In this case-control study, ...
متن کاملCardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer.
Trastuzumab (Herceptin) is a humanised monoclonal antibody that specifically targets HER2-positive breast cancer cells. Safety data collected from pivotal trials with trastuzumab indicate that this therapy is generally well tolerated. However trials of the combination of trastuzumab plus chemotherapy, and in particular chemotherapy with anthracyclines, have revealed an elevated incidence of car...
متن کاملPsoriasis Induced by Trastuzumab (Herceptin®)
Trastuzumab (Herceptin), a humanized monoclonal antibody, is a cancer drug developed to target the human epidermal receptor (HER) 2, which is overexpressed in some cancer cells. Cutaneous side effects, such as folliculitis, xerosis, and alopecia have not been reported with therapies targeting HER2, in spite of the frequent observances of such with the therapies targeting the epidermal growth fa...
متن کاملthe speech act of advice and the introvert/extrovert distinction among iranian efl university students
the aim of this study is to examine the difference between the introverts and extroverts in preferred advice-giving style. furthermore, it explores the difference between l1 (persian) and l2 (english) regarding the giving of advice for the extroverts and introverts separately. it investigates whether an extrovert or introvert gives advice in the same manner in his l1 (persian) and l2 (english) ...
منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
basic and clinical cancer researchجلد ۶، شماره ۲، صفحات ۲۷-۳۴
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023